BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease

被引：3

作者：

Hagen, Melanie ^{[1
]}

Bucci, Laura ^{[1
]}

Boeltz, Sebastian ^{[1
]}

Noethling, Danae-Mona ^{[1
]}

Rothe, Tobias ^{[1
]}

Anoshkin, Kirill ^{[1
]}

Raimondo, Maria G. ^{[1
]}

Tur, Carlo ^{[1
]}

Wirsching, Andreas ^{[1
]}

Wacker, Jochen ^{[1
]}

Duesing, Christina ^{[2
]}

Distler, Jorg H. W. ^{[2
]}

Kuwert, Torsten ^{[1
]}

Bozec, Aline ^{[1
]}

Ramming, Andreas ^{[1
]}

Schett, Georg ^{[1
]}

Grieshaber-Bouyer, Ricardo ^{[1
]}

机构：

[1] Friedrich Alexander Univ Erlangen Nuremberg, Erlangen, Germany

[2] Heinrich Heine Univ Dusseldorf, Dusseldorf, Germany

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 391卷 / 09期

关键词：

D O I：

10.1056/NEJMc2408786

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：867 / 869

页数：3

共 50 条

[1] BCMA-targeted Bispecific T Cell-engager Therapy of Autoimmune Disease
Bucci, Laura
Hagen, Melanie
Boeltz, Sebastian
Noethling, Danae-Mona
Rothe, Tobias
Raimondo, Maria Gabriella
Tur, Carlo
Wirsching, Andreas
Wacker, Jochen
Bozec, Aline
Schett, Georg
Grieshaber-Bouyer, Ricardo
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 5403 - 5405
[2] FDA approves first BCMA-targeted CAR-T cell therapy
Asher Mullard
Nature Reviews Drug Discovery, 2021, 20 : 332 - 332
[3] FDA approves second BCMA-targeted CAR-T cell therapy
Asher Mullard
Nature Reviews Drug Discovery, 2022, 21 : 249 - 249
[4] FDA approves second BCMA-targeted CAR-T cell therapy
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (04) : 249 - 249
[5] FDA approves first BCMA-targeted CAR-T cell therapy
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (05) : 332 - 332
[6] GPRC5D-targeted bispecific bolsters T-cell-engager pipeline
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (02) : 90 - 90
[7] GPRC5D-targeted bispecific bolsters T-cell-engager pipeline
Asher Mullard
Nature Reviews Drug Discovery, 2023, 22 : 90 - 90
[8] Clinical outcomes of patients with multiple myeloma following disease progression after BCMA-targeted CAR T-cell therapy
Subramanian, Naveen G.
Pleitez, Hector Garcia
Pasvolsky, Oren
Kalariya, Nilesh
Patel, Krina K.
Ferreri, Christopher J.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[9] Safety of Bispecific T-cell Engager Therapy in Autoimmune Disease
Hagen, Melanie
Bucci, Laura
Boeltz, Sebastian
Noethling, Danae-Mona
Rothe, Tobias
Raimondo, Maria Gabriella
Tur, Carlo
Wirsching, Andreas
Wacker, Jochen
Bozec, Aline
Schett, Georg
Grieshaber-Bouyer, Ricardo
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2299 - 2300
[10] Mezigdomide Enhances Activity of BCMA-Targeted Cellular and T-Cell Engager Therapies and Mitigates Immune Toxicity in Preclinical Models of Multiple Myeloma
Larrayoz, Marta
Bjorklund, Chad Chad
Jimenez, Maddalen
Lozano, Teresa
Sanz, Sonia
Arriazu, Elena
Zon, Rebecca
Rodriguez-Madoz, Juan Roberto
Paiva, Bruno
Rodriguez-Otero, Paula
San-Miguel, Jesus
Prosper, Felipe
Jose Lasarte, Juan
Ebert, Benjamin
Hagner, Patrick
Martinez-Climent, Jose Angel
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S6 - S7

← 1 2 3 4 5 →